期刊文献+

代谢组学在多囊卵巢综合征研究中的应用 被引量:3

暂未订购
导出
摘要 多囊卵巢综合征(PCOS)是育龄期妇女常见的一种复杂的内分泌及代谢紊乱疾病,具有高度异质性的特点.主要临床表现为月经失调、不孕、多毛和痤疮,并伴有排卵功能紊乱和高雄激素血症,发病率为4%~12%,是引起不排卵性不孕的主要原因.目前其发病机制尚不明确.作为系统生物学研究的关键技术和方法,代谢组学是继基因组学和蛋白质组学之后新近发展起来的一门学科,其通过系统研究代谢产物的变化规律,跳过体内复杂的调控过程揭示生命活动的代谢本质.代谢组学技术自提出后主要用于临床诊断疾病和药物的药理毒理研究.
机构地区 山东中医药大学
出处 《山东医药》 CAS 2013年第34期95-97,共3页 Shandong Medical Journal
基金 国家自然科学基金资助项目(81273667)
  • 相关文献

参考文献16

  • 1Brindle JT, Antti H, Holmes E, et al. Rapid and noninva-sive di- agnosis of the presence and severity of coronary heart disease u- singlH-NMR-basedmetabonomics[ J ]. Nat Med, 2002,8 (12) : 1439-1444.
  • 2Makinen VP, Soininen P, Forsblom C, et al. Diagnosing diabetic nephropathy bylH NMR metabonomics of serum[ J]. MAGMA, 2006,19(6) :281-296.
  • 3Xu GW, Liebich H. Normal and modified nucleosides in urine as potential tumor markers determined by MEKC and HPLC[J]. Am Clin Lab, 2001,20(6) :22-32.
  • 4Maliqueo M, Galgani JE, Prrez-Bravo F, et al. Relationship of se- rum adipoeyte-derived proteins with insulin sensitivity and repro-ductive features in pre-pubertal and pubertal daughters of polycystic ovary syndrome women [ J ]. Eur J Obstet Gynecol Reprod Biol, 2012, 23(2) :55-58.
  • 5Aleyasin A, Aghahoseini M, Mokhtar S, et al. Anti-mullerian hor- mone as a predictive factor in assisted reproductive technique of polycystic ovary syndrome patients[J]. Acta Med Iran, 2011, 49 (11) :715-720.
  • 6Parco S, Novelli C, Vascotto F, et al. Serum anti-Mfillerian hor- mone as a predictive marker of polycystic ovarian syndrome [ J ]. Int J Gen Med, 2011,4(11) :759-763.
  • 7Arya BK, Haq AU, Chaudhury K. Oocyte quality reflected by follicular fluid analysis in poly cystic ovary syndrome (PCOS) : a hypothesis based on intermediates of energy metabolism [ J 1. Med Hypotheses, 2012,78 ( 4 ) :475-478.
  • 8Insenser M, Montes-Nieto R, Murri M, et al. Proteomic and metabolomic approaches to the study of polycystic ovary syndrome [ J ]. Mol Cell Endocrinol, 2013, 370 ( 1-2 ) :65-77.
  • 9Atiomo W, Daykin CA. Metabolomic biomarkers in women with polycystic ovary syndrome : a pilot study [ J ]. Mol Hum Reprod, 2012, 18 ( 11 ) :546-553.
  • 10Vinaixa M, Rodriguez MA, Samino S,et al. Metabolomics reveals reduction of metabolic oxidation in women with polycystic ovarysyndrome after pioglitazone-flutamide-metformin polytherapy [ J]. PLoS One, 2011, 6(12) :e29052.

二级参考文献27

  • 1王东生,袁肇凯,陈方平,黄献平,卢芳国,谢梦洲,郭志华,谭光波,毛以林.养心通脉片对动脉粥样硬化大鼠痰瘀病机的影响[J].中国中医急症,2005,14(3):250-251. 被引量:6
  • 2吴红金,马增春,高月,王升启.蛋白质组学技术对冠心病血瘀证相关蛋白的研究[J].中西医结合心脑血管病杂志,2005,3(3):189-191. 被引量:58
  • 3齐炼文,李萍,赵静.代谢组学与中医药现代研究[J].世界科学技术-中医药现代化,2006,8(6):79-86. 被引量:35
  • 4黄献平,袁肇凯,谭光波,毛以林,卢芳国,胡志希,田松,李杰,孙贵香.冠心病血瘀证患者血管紧张素转换酶基因多态性的检测分析[J].中医杂志,2007,48(1):65-68. 被引量:19
  • 5NICHOLSON JK,LINDON JC,HOLMES E.'Metabonomics':understanding the metabolic responses of livi- systems topathophysiologieal stimuli multivariate statistical analysisof biological NMR spectroscopic data[J].Xenobiotica,1999,29(11):1181-1189.
  • 6LINDON JC,NICHOLSON JK,HOLMES E,et al.Metabonomics:metabolic processes studied by NMR spectros-copy of biofluids[J].Concepts Magn Resort,2000,12(5):289-320.
  • 7GERMAN J B,BAUMAN D E,BURRIN D G,et al.Metabonomics in the opening decade of the 21st century:building the roads to individualized health[J].Nature,2004,134(10):2729.
  • 8WATERS NJ,WATERFIELD CJ,FARRANT RD,et al.Metabonomic deconvolution of embedded toxicity:application to thioacetamide hepato-and nephrotoxicity[J].Chem Res Toxicol,2005,18(4):639-654.
  • 9BOLLARD M E,STANLEY E G,LINDON J C,et al.NMR-based metabonomics approaches for evaluating physiological influences on biofluid composition[J].NMR Biomed,2005,18:143-162.
  • 10LINDON JC,HOLMES E,NICHOLSON JK.Pattern recognition methods and applications in biomedical magnetic resonance[J].Prog Nucl Magn Reson Spectrosc,2001,39(1):1-40.

共引文献62

同被引文献20

  • 1余亚信,李学军,闫冰,王丽英,张惠杰,杨叔禹.胰岛素增敏剂治疗多囊卵巢综合征疗效的系统评价[J].中华临床医师杂志(电子版),2011,5(22):6671-6679. 被引量:16
  • 2Teede H,Deeks A,Moran L,et al.Polyeysfic ovary cyndrome:a complex condition with psychological,reproductive and metabolic manifestations that impacts on health across the lifespan[J].BMC MED,2010,8(1):41.
  • 3Rupal Shroff,Angela Kirschner,Michelle Maifeld,et al.Young Obese Women with Polycystic ovary syndrome have Evidence of Early coronary Atherosclerosis[J].J Clin Endocrinol Metab,2007 Se Pll[Epub ahead of print].
  • 4Rotterdam ESHRE ASRM Sponsored PCOS consensus workshop group.Revised 2003 consensus on diagnostic critera and longterm health risks related to polycystic ovary syndrome(PCOS)[J].Hum Reprod,2004,19(1):41-47.
  • 5REPACI A,GAMBINEKI A,PASQUALI R,et al.The role of low grade inflammation in the polycystic ovary syndrome[J].Mol cell Endocrinol,2011,335(1):30-41.
  • 6AZZIZ R,MARIN C,HOQ L,et al.Health care related economic burden of the polycystic ovary syndrome during the reproductive life span[J].J Clin Endocrinol Metab,2009,90(8):4650-4658.
  • 7Galazis N,Iacovou C,Haoula Z,et al.Metabolomic biomarkers of impaired glucose tolerance and type 2 diabetes mellitus with a poteneial for risk stratification in women with polycystic ovary syndrome[J].Eur J Obsert Gynecol Reprod Biol,2012,160(2):121-130.
  • 8Francesco Cosentino,Gabriele Egidy Assenza.Diabetes and Inflammation[J]. Herz . 2004 (8)
  • 9冯巧飞,刘宏,何援利,潘石蕾.胰岛素增敏剂联合达英-35治疗多囊卵巢综合征疗效观察[J].广东医学,2009,30(8):1171-1173. 被引量:23
  • 10魏巍,孙壮状,安媛,李力男,关咏梅,王卓然.达英-35与胰岛素增敏剂治疗多囊卵巢综合征后促排卵药物的效果观察[J].实用妇产科杂志,2009,25(10):618-621. 被引量:36

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部